Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia

Masashi Shiomi, Hiroaki Takeda, Yasuhiro Irino, Norie Kimura, Satoshi Yamada, Nobue Kuniyoshi, Akio Kikumori, Yu Koike, Tomonari Koike, Masaru Yoshida, Yoshihiro Izumi, Masakazu Shinohara, Takeshi Bamba, Tatsuro Ishida

Research output: Contribution to journalArticle

Abstract

Background and aims: The development of serum markers specific for coronary lesions is important to prevent coronary events. However, analyses of serum markers in humans are affected by environmental factors and non-target diseases. Using an appropriate model animal can reduce these effects. To identify specific markers for coronary atherosclerosis, we comprehensively analyzed the serum of WHHLMI rabbits, which spontaneously develop coronary atherosclerosis. Methods: Female WHHLMI rabbits were fed standard chow. Serum and plasma were collected under fasting at intervals of 4 months from 4 months old, and a total of 313 lipid molecules, 59 metabolites, lipoprotein lipid levels, and various plasma biochemical parameters were analyzed. The severity of coronary lesions was evaluated with cross-sectional narrowing (CSN) corrected with a frequency of 75%–89% CSN and CSN> 90%. Results: There was a large variation in the severity of coronary lesions in WHHLMI rabbits despite almost no differences in plasma biochemical parameters and aortic lesion area between rabbits with severe and mild coronary lesions. The metabolites and lipid molecules selected as serum markers for coronary atherosclerosis were lysophosphatidylcholine (LPC) 22:4 and diacylglycerol 18:0–18:0 at 4 months old, LPC 20:4 (sn-2), ceramide d18:1–18:2, citric acid plus isocitric acid, and pyroglutamic acid at 8 months old, and phosphatidylethanolamine plasminogen 16:1p-22:2 at 16 months old. Conclusions: These serum markers were coronary lesion-specific markers independent of cholesterol levels and aortic lesions and may be useful to detect patients who develop cardiovascular disease.

Original languageEnglish
Pages (from-to)18-23
Number of pages6
JournalAtherosclerosis
Volume284
DOIs
Publication statusPublished - May 1 2019

Fingerprint

Hyperlipoproteinemia Type II
Coronary Artery Disease
Animal Models
Biomarkers
Rabbits
Lysophosphatidylcholines
Lipids
Pyrrolidonecarboxylic Acid
Ceramides
Plasminogen
Diglycerides
Serum
Citric Acid
Lipoproteins
Fasting
Cardiovascular Diseases
Cholesterol

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia. / Shiomi, Masashi; Takeda, Hiroaki; Irino, Yasuhiro; Kimura, Norie; Yamada, Satoshi; Kuniyoshi, Nobue; Kikumori, Akio; Koike, Yu; Koike, Tomonari; Yoshida, Masaru; Izumi, Yoshihiro; Shinohara, Masakazu; Bamba, Takeshi; Ishida, Tatsuro.

In: Atherosclerosis, Vol. 284, 01.05.2019, p. 18-23.

Research output: Contribution to journalArticle

Shiomi, M, Takeda, H, Irino, Y, Kimura, N, Yamada, S, Kuniyoshi, N, Kikumori, A, Koike, Y, Koike, T, Yoshida, M, Izumi, Y, Shinohara, M, Bamba, T & Ishida, T 2019, 'Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia', Atherosclerosis, vol. 284, pp. 18-23. https://doi.org/10.1016/j.atherosclerosis.2019.02.020
Shiomi, Masashi ; Takeda, Hiroaki ; Irino, Yasuhiro ; Kimura, Norie ; Yamada, Satoshi ; Kuniyoshi, Nobue ; Kikumori, Akio ; Koike, Yu ; Koike, Tomonari ; Yoshida, Masaru ; Izumi, Yoshihiro ; Shinohara, Masakazu ; Bamba, Takeshi ; Ishida, Tatsuro. / Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia. In: Atherosclerosis. 2019 ; Vol. 284. pp. 18-23.
@article{98ece88c8e4348998cad6040e9e8484b,
title = "Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia",
abstract = "Background and aims: The development of serum markers specific for coronary lesions is important to prevent coronary events. However, analyses of serum markers in humans are affected by environmental factors and non-target diseases. Using an appropriate model animal can reduce these effects. To identify specific markers for coronary atherosclerosis, we comprehensively analyzed the serum of WHHLMI rabbits, which spontaneously develop coronary atherosclerosis. Methods: Female WHHLMI rabbits were fed standard chow. Serum and plasma were collected under fasting at intervals of 4 months from 4 months old, and a total of 313 lipid molecules, 59 metabolites, lipoprotein lipid levels, and various plasma biochemical parameters were analyzed. The severity of coronary lesions was evaluated with cross-sectional narrowing (CSN) corrected with a frequency of 75{\%}–89{\%} CSN and CSN> 90{\%}. Results: There was a large variation in the severity of coronary lesions in WHHLMI rabbits despite almost no differences in plasma biochemical parameters and aortic lesion area between rabbits with severe and mild coronary lesions. The metabolites and lipid molecules selected as serum markers for coronary atherosclerosis were lysophosphatidylcholine (LPC) 22:4 and diacylglycerol 18:0–18:0 at 4 months old, LPC 20:4 (sn-2), ceramide d18:1–18:2, citric acid plus isocitric acid, and pyroglutamic acid at 8 months old, and phosphatidylethanolamine plasminogen 16:1p-22:2 at 16 months old. Conclusions: These serum markers were coronary lesion-specific markers independent of cholesterol levels and aortic lesions and may be useful to detect patients who develop cardiovascular disease.",
author = "Masashi Shiomi and Hiroaki Takeda and Yasuhiro Irino and Norie Kimura and Satoshi Yamada and Nobue Kuniyoshi and Akio Kikumori and Yu Koike and Tomonari Koike and Masaru Yoshida and Yoshihiro Izumi and Masakazu Shinohara and Takeshi Bamba and Tatsuro Ishida",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.atherosclerosis.2019.02.020",
language = "English",
volume = "284",
pages = "18--23",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Identification of novel serum markers for the progression of coronary atherosclerosis in WHHLMI rabbits, an animal model of familial hypercholesterolemia

AU - Shiomi, Masashi

AU - Takeda, Hiroaki

AU - Irino, Yasuhiro

AU - Kimura, Norie

AU - Yamada, Satoshi

AU - Kuniyoshi, Nobue

AU - Kikumori, Akio

AU - Koike, Yu

AU - Koike, Tomonari

AU - Yoshida, Masaru

AU - Izumi, Yoshihiro

AU - Shinohara, Masakazu

AU - Bamba, Takeshi

AU - Ishida, Tatsuro

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Background and aims: The development of serum markers specific for coronary lesions is important to prevent coronary events. However, analyses of serum markers in humans are affected by environmental factors and non-target diseases. Using an appropriate model animal can reduce these effects. To identify specific markers for coronary atherosclerosis, we comprehensively analyzed the serum of WHHLMI rabbits, which spontaneously develop coronary atherosclerosis. Methods: Female WHHLMI rabbits were fed standard chow. Serum and plasma were collected under fasting at intervals of 4 months from 4 months old, and a total of 313 lipid molecules, 59 metabolites, lipoprotein lipid levels, and various plasma biochemical parameters were analyzed. The severity of coronary lesions was evaluated with cross-sectional narrowing (CSN) corrected with a frequency of 75%–89% CSN and CSN> 90%. Results: There was a large variation in the severity of coronary lesions in WHHLMI rabbits despite almost no differences in plasma biochemical parameters and aortic lesion area between rabbits with severe and mild coronary lesions. The metabolites and lipid molecules selected as serum markers for coronary atherosclerosis were lysophosphatidylcholine (LPC) 22:4 and diacylglycerol 18:0–18:0 at 4 months old, LPC 20:4 (sn-2), ceramide d18:1–18:2, citric acid plus isocitric acid, and pyroglutamic acid at 8 months old, and phosphatidylethanolamine plasminogen 16:1p-22:2 at 16 months old. Conclusions: These serum markers were coronary lesion-specific markers independent of cholesterol levels and aortic lesions and may be useful to detect patients who develop cardiovascular disease.

AB - Background and aims: The development of serum markers specific for coronary lesions is important to prevent coronary events. However, analyses of serum markers in humans are affected by environmental factors and non-target diseases. Using an appropriate model animal can reduce these effects. To identify specific markers for coronary atherosclerosis, we comprehensively analyzed the serum of WHHLMI rabbits, which spontaneously develop coronary atherosclerosis. Methods: Female WHHLMI rabbits were fed standard chow. Serum and plasma were collected under fasting at intervals of 4 months from 4 months old, and a total of 313 lipid molecules, 59 metabolites, lipoprotein lipid levels, and various plasma biochemical parameters were analyzed. The severity of coronary lesions was evaluated with cross-sectional narrowing (CSN) corrected with a frequency of 75%–89% CSN and CSN> 90%. Results: There was a large variation in the severity of coronary lesions in WHHLMI rabbits despite almost no differences in plasma biochemical parameters and aortic lesion area between rabbits with severe and mild coronary lesions. The metabolites and lipid molecules selected as serum markers for coronary atherosclerosis were lysophosphatidylcholine (LPC) 22:4 and diacylglycerol 18:0–18:0 at 4 months old, LPC 20:4 (sn-2), ceramide d18:1–18:2, citric acid plus isocitric acid, and pyroglutamic acid at 8 months old, and phosphatidylethanolamine plasminogen 16:1p-22:2 at 16 months old. Conclusions: These serum markers were coronary lesion-specific markers independent of cholesterol levels and aortic lesions and may be useful to detect patients who develop cardiovascular disease.

UR - http://www.scopus.com/inward/record.url?scp=85062690324&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85062690324&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2019.02.020

DO - 10.1016/j.atherosclerosis.2019.02.020

M3 - Article

VL - 284

SP - 18

EP - 23

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

ER -